Same molecule, different paths: Where value goes in cross-border dealmaking in a new era

Drew Armstrong is the Executive Editor of Endpoints News, and joined the newsroom in 2022. He has nearly two decades of experience as a health care journalist in New York and Washington, D.C. most recently a 12-year career at Bloomberg News. There, he led the newsroom's U.S. coverage of the Covid-19 pandemic, developed its "Prognosis" health care vertical and managed a team of a dozen journalists covering every aspect of the American health care system. Prior to Bloomberg, he spent five years covering U.S. health policy at Congressional Quarterly, where he wrote about the enactment of the Affordable Care Act. His work as a writer, editor and data project manager has won or been recognized by multiple journalism awards, and he has appeared regularly on television and radio to discuss his work. Armstrong lives in the New York City area with his family.

Zairan Liu is Chief International Business Officer at PharmCube, where she leads the company's global market expansion, bringling leading data and intelligence solution to meet global customer's demand. Before PharmCube, she spent eight years at IQVIA strategy consulting, leading corporate and portfolio strategy, commercial due diligence, and market access engagements for top 20 pharmaceutical companies, shaping where they invested and how they priced their assets across the US, Europe, and Asia-Pacific. Trained as a biophysicist at UCSF, with a background in computational and systems biology, she works to bring breakthrough innovation to the markets that value it most.